The California Institute for Regenerative Medicine has agreed to spend $40 million toward one or two Stem Cell Genomics Centers of Excellence to give state scientists greater access to genomic tools. The investment "will give California researchers unprecedented opportunities for better understanding the cells they are working with and advancing those cells toward therapies for patients," CIRM's president said.

Related Summaries